Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Meningitis Vaccines
Findings from E. Bingen and co-authors provide new insights into meningitis vaccines
June 4th, 2008
A new study, 'Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation,' is now available. According to recent research from Paris, France, "The French Pediatric Infectious Diseases Group set up an active surveillance network to analyze the clinical and biological features of pneumococcal meningitis and the impact of the seven-valent pneumococcal conjugate vaccine (PCV7). From 2001 to 2005, 234 pediatric wards working with 166 microbiology laboratories enrolled all children with pneumococcal meningitis." "Risk factors, signs and symptoms, vaccination status, cerebrospinal fluid analysis, treatments and case fatality rates were recorded. One...
Source: Vaccine Weekly (2008-06-04)
|
